The Wiskott-Aldrich Syndrome Protein (WASP): Roles in signaling and cytoskeletal organization

Annual Review of Immunology

Volumn 17, Issue , 1999, Pages 905-929

  Snapper, Scott B ^a,b,c   Rosen, Fred S ^a,c  

^a CENTER FOR BLOOD RESEARCH   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Actin cytoskeleton; Lymphocyte signaling; N WASP; WASP; Wiskott Aldrich Syndrome

Indexed keywords

ACTIN; CYTOSKELETON PROTEIN; UNCLASSIFIED DRUG; WISKOTT ALDRICH SYNDROME PROTEIN;

CHROMOSOME MAP; CYTOSKELETON; GENE EXPRESSION; GENE MUTATION; GENETIC LINKAGE; HUMAN; IMMUNE DEFICIENCY; LYMPHOCYTE FUNCTION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN LOCALIZATION; REVIEW; SIGNAL TRANSDUCTION; WISKOTT ALDRICH SYNDROME;

ANIMALS; BLOOD PLATELETS; CHROMOSOME MAPPING; CYTOSKELETON; GTP PHOSPHOHYDROLASES; GTP-BINDING PROTEINS; GTPASE-ACTIVATING PROTEINS; HUMANS; LYMPHOCYTES; MICE; MUTATION; NERVE TISSUE PROTEINS; PHENOTYPE; PROTEINS; SIGNAL TRANSDUCTION; WISKOTT-ALDRICH SYNDROME; WISKOTT-ALDRICH SYNDROME PROTEIN; WISKOTT-ALDRICH SYNDROME PROTEIN, NEURONAL;

EID: 0033012399     PISSN: 07320582     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.immunol.17.1.905     Document Type: Review

References (172)

1. Wiskott A. 1936. Familiärer, angeborener Morbus Werlhoffi? Monatsschr. Kinderheil. 68:212-16
2. Aldrich RA, Steinberg AG, Campbell DC. 1954. Pedigree demonstrating a sex-linked recessive condition characterized by draining cars, eczematoid dermatitis and bloody diarrhea. Pediatrics 13:133-39
3. Blaese RM, Strober W, Brown RS, Waldmann TA. 1968. The Wiskott-Aldrich syndrome. A disorder with a possible defect in antigen processing or recognition. Lancet 1:1056-61
4. Cooper MD, Chase HP, Lowman JT, Krivit W, Good RA. 1968, Wiskott-Aldrich syndrome. An immunologic deficiency disease involving the afferent limb of immunity. Am. J. Med. 44:499-513
5. Ochs HD, Slichter SJ, Harker LA, Von Behrens WE, Clark RA, Wedgwood RJ. 1980. The Wiskott-Aldrich syndrome: studies of lymphocytes, granulocytcs, and platelets. Blood 55:243-52
6. Ochs HD, Rosen FS. 1998. The Wiskott-Aldrich Syndrome. In Primary Immunodeficiency Diseases: A Molecular and Genetic Approach, ed. HD Ochs, CIE Smith, JM Puck, Oxford, UK: Oxford Univ. Press. In press
7. Sullivan KE, Mullen CA, Blaese RM, Winkelstein JA. 1994. A multiinstitutional survey of the Wiskott-Aldrich syndrome. J. Pediatr. 125:876-85
8. Canales ML, Mauer AM. 1967. Sex-linked hereditary thrombocytopenia as a variant of Wiskott-Aldrich syndrome. N. Engl. J. Med. 277:899-901
9. Amaya CA, Dorantes S, Toro AH, Bello A, Cuellar J. 1973. Attenuated form of Wiskott-Aldrich syndrome. J. Pediatr. 82:175-6
10. Chiaro JJ, Dharmkrong-at A, Bloom GE. 1972. X-linked thrombocytopenic purpura. I. Clinical and genetic studies of a kindred. Am. J. Dis. Child. 123:565-68
11. Notarangelo LD, Parolini O, Porta F, Locatelli F, Lanfranchi A, Marconi M, Nespoli L, Albertini A, Craig IW, Ugazio AG. 1991. Analysis of X-chromosome inactivation and presumptive expression of the Wiskott-Aldrich syndrome (WAS) gene in hematopoietic cell lineages of a thrombocytopenic carrier female of WAS. Hum. Genet. 88:237-41
12. Stormorken H, Helium B, Egeland T, Abrahamsen TG, Hovig T. 1991. X-linked thrombocytopenia and thrombocytopathia: attenuated Wiskott-Aldrich syndrome. Functional and morphological studies of platelets and lymphocytes. Thromb. Haemost. 65:300-5
13. Parkman R, Rappeport J, Geha R, Belli J, Cassady R, Levey R, Nathan DG, Rosen FS. 1978. Complete correction of the Wiskott-Aldrich syndrome by allogeneic bone-marrow transplantation. N. Eng. J. Med. 298:921-27
14. Peacocke M, Siminovitch KA. 1987. Linkage of the Wiskott-Aldrich syndrome with polymorphic DNA sequences from the human X chromosome. Proc. Natl. Acad. Sci. USA 84: 3430-33
15. Kwan SP, Sandkuyl LA, Blaese M, Kunkel LM, Bruns G, Parmley R, Skarshaug S, Page DC, Ott J, Rosen FS. 1988. Genetic mapping of the Wiskott-Aldrich syndrome with two highly-linked polymorphic DNA markers. Genomics 3:39-43
16. Kwan SP, Lehner T, Hagemann T, Lu B, Blaese M, Ochs H, Wedgwood R, Ott J, Craig IW, Rosen FS. 1991. Localization of the gene for the Wiskott-Aldrich syndrome between two flanking markers, TTMP and DXS255, on Xp11.22-Xp11.3. Genomics 10:29-33
17. Kwan SP, Hagemann TL, Radtke BE, Blaese RM, Rosen FS. 1995. Identification of mutations in the Wiskott-Aldrich syndrome gene and characterization of a polymorphic dinucleotide repeat at DXS6940, adjacent to the disease gene. Proc. Natl. Acad. Sci. USA 92:4706-10
18. Kwan SP, Hagemann TL, Blaese RM, Rosen FS. 1995. A high-resolution map of genes, microsatellite markers, and new dinucleotide repeats from UBE1 to the GATA lokus in the region Xp11.23. Genomics 29:247-52
19. Derry JM, Ochs HD, Francke U. 1994. Isolation of a novel gene mutated in Wiskott-Aldrich syndrome [published erratum appears in Cell 79(5): following 922, 1994]. Cell 78:635-44
20. Zhu Q, Zhang M, Blaese RM, Derry JM, Junker A, Francke U, Chen SH, Ochs HD. 1995. The Wiskott-Aldrich syndrome and X-linked congenital thrombocytopenia are caused by mutations of the same gene. Blood 86:3797-804
21. Villa A, Notarangelo L, Macchi P, Mantuano E, Cavagni G, Brugnoni D, Strina D, Patrosso MC, Ramenghi U, Sacco MG, et al. 1995. X-linked thrombocytopenia and Wiskott-Aldrich syndrome are allelic diseases with mutations in the WASP gene. Nature Genetics 9:414-17
22. Zhu Q, Watanabe C, Liu T, Hollenbaugh D, Blaese RM, Kanner SB, Aruffo A, Ochs HD. 1997. Wiskott-Aldrich syndrome/X-linked thrombocytopenia: WASP gene mutations, protein expression, and phenotype. Blood 90:2680-89
23. Schwarz K, Nonoyama S, Peitsch M, de Saint Basile G, Espanol T, Rasth A, Fischer A, Freitag K, Friedrich W, Fugmann S, Hossle H, Jones A, Kinnon C, Meindl A, Notarangelo L, Wechsler A, Weiss M, Ochs H. 1996. WASPbase: a database of WAS-and XLT-causing mutations. Immunol. Today 17:496-501
24. Gealy WJ, Dwyer JM, Harley JB. 1980. Allelic exclusion of glucose-6-phosphate dehydrogenase in platelets and T lymphocytes from a Wiskott-Aldrich syndrome carrier. Lancet 1:63-65
25. Prchal JT, Carroll AJ, Prchal JF, Crist WM, Skalka HW, Gealy WJ, Harley J, Malluh A. 1980. Wiskott-Aldrich syndrome: cellular impairments and their implication for carrier detection. Blood 56:1048-54
26. Fearon ER, Kohn DB, Winkelstein JA, Vogelstein B, Blaese RM. 1988. Carrier detection in the Wiskott Aldrich syndrome. Blood 72:1735-39
27. Greer WL, Kwong PC, Peacocke M, Ip P, Rubin LA, Siminovitch KA. 1989. X-chromosome inactivation in the Wiskott-Aldrich syndrome: a marker for detection of the carrier state and identification of cell lineages expressing the gene defect. Genomics 4:60-67
28. Puck JM, Siminovitch KA, Poncz M, Greenberg CR, Rottem M, Conley ME. 1990. Atypical presentation of Wiskott-Aldrich syndrome: diagnosis in two unrelated males based on studies of maternal T cell X chromosome inactivation. Blood 75:2369-74
29. Wengler G, Gorlin JB, Williamson JM, Rosen FS, Bing DH. 1995. Nonrandom inactivation of the X chromosome in early lineage hematopoietic cells in carriers of Wiskott-Aldrich syndrome. Blood 85:2471-77
30. Remold-O'Donnell E, Rosen FS, Kenney DM. 1996. Defects in Wiskott-Aldrich syndrome blood cells. Blood 87:2621-31
31. Molina IJ, Sancho J, Terhorst C, Rosen FS, Remold-O'Donnell E. 1993. T cells of patients with the Wiskott-Aldrich syndrome have a restricted defect in proliferative responses. J. Immunol. 151: 4383-90
32. Molina IJ, Kenney DM, Rosen FS, Remold-O'Donnell E. 1992. T cell lines characterize events in the pathogenesis of the Wiskott-Aldrich syndrome. J. Exp. Med. 176:867-74
33. Simon HU, Mills GB, Hashimoto S, Siminovitch KA. 1992. Evidence for defective transmembrane signaling in B cells from patients with Wiskott-Aldrich syndrome. J. Clin. Invest. 90:1396-405
34. Henriquez NV, Rijkers GT, Zegers BJ. 1994. Antigen receptor-mediated transmembrane signaling in Wiskott-Aldrich syndrome. J. Immunol. 153:395-99
35. Kenney D, Cairns L, Remold-O'Donnell E. Peterson J, Rosen FS, Parkman R. 1986. Morphological abnormalities in the lymphocytes of patients with the Wiskott-Aldrich syndrome. Blood 68: 1329-32
36. Gallego M, Santamaria M, Pena J, Molina I. 1997. Detective actin reorganization and polymerization of Wiskott-Aldrich T cells in response to CD3-mediated stimulation. Blood 90: 3089-97
37. Facchetti F, Blanzuoli L, Vermi W, Notarangelo LD, Giliani S, Fiorini M, Fasth A, Stewart DM, Nelson DL. 1998. Defective actin polymerization in EBV-transformed B-cell lines from patients with the Wiskott-Aldrich syndrome. J. Pathol. 185:99-107
38. Remold-O'Donnell E, Van BJ, Kenney DM. 1992. Effect of platelet calpain on normal T-lymphocyte CD43: hypothesis of events in the Wiskott-Aldrich syndrome. Blood 79:1754-62
39. Yonemura S, Nagafuchi A, Sato N, Tsukita S. 1993. Concentration of an integral membrane protein, CD43 (leukosialin, sialophorin), in the cleavage furrow through the interaction of its cytoplasmic domain with actin-based cytoskeletons. J. Cell Biol. 120:437-49
40. Parkman R, Remold-O'Donnell E, Kenney DM, Perrine S, Rosen FS. 1981. Surface protein abnormalities in lymphocytes and platelets from patients with Wiskott-Aldrich syndrome. Lancet 2:1387-89
41. Remold-O'Donnell E, Kenney DM, Parkman R, Cairns L, Savage B, Rosen FS. 1984. Characterization of a human lymphocyte surface sialoglycoprotein that is defective in Wiskott-Aldrich syndrome. J. Exp. Med. 159:1705-23
42. Pallant A, Eskenazi A, Mattei MG, Fournier RE, Carlsson SR, Fukudu M, Prelinger JG. 1989. Characterization of cDNAs encoding human leukosialin and localization of the leukosialin gene to chromosome 16. Proc. Natl. Acad. Sci. USA 86:1328-32
43. Shelley CS, Remold-O'Donnell E, Davis AEd, Bruns GA, Rosen FS, Carroll MC, Whitehead AS. 1989. Molecular characterization of sialophorin (CD43), the lymphocyte surface sialoglycoprotein defective in Wiskott-Aldrich syndrome [published erratum appears in Proc. Natl. Acad. Sci. USA. 1989. 86(12):.4689]. Proc. Natl. Acad. Sci. USA 86:2819-23
44. Gerwin N, Friedrich C, Perez-Atayde A, Rosen FS, Gutierrez-Ramos JC. 1996. Multiple antigens are altered on T and B lymphocytes from peripheral blood and spleen of patients with Wiskott-Aldrich syndrome. Clin. Exp. Immunol. 106:208-17
45. Kenney DM. 1990. Wiskott-Aldrich syndrome and related X-linked thrombocytopenia. Curr. Opin. Pediatr. 2:931-34
46. Lum LG, Tubergen DG, Corash L, Blaese RM. 1980. Splenectomy in the management of the thrombocytopenia of the Wiskott-Aldrich syndrome. N. Engl. J. Med. 302:892-96
47. Krivit W, Yunis E, White JG. 1966. Platelet survival studies in Aldrich syndrome. Pediatrics 37:339-41
48. Pearson HA, Shulman NR, Oski FA, Eitzman DV. 1966. Platelet survival in Wiskott-Aldrich syndrome. J. Pediatr. 68:754-60
49. Baldini MG. 1972. Nature of the platelet defect in the Wiskott-Aldrich syndrome. Ann. N. Y. Acad. Sci. 201:437-44
50. Grottum KA, Hovig T, Holmsen H, Abrahamsen AF, Jeremic M, Seip M. 1969. Wiskott-Aldrich syndrome: qualitative platelet defects and short platelet survival. Br. J. Haematol. 17:373-88
51. Kuramoto A, Steiner M, Baldini MG, 1970. Lack of platelet response to stimulation in the Wiskott-Aldrich syndrome. N. Engl. J. Med. 282:475-79
52. Marone G, Albini F, di ML, Quattrin S, Poto S, Condorelli M. 1986. The Wiskott-Aldrich syndrome: studies of platelets, basophils and polymorphonuclear leucocytes. Br. J. Haematol. 62:737-45
53. Verhoeven AJ, van Oostrum IE, van Haarlem H, Akkerman JW. 1989. Impaired energy metabolism in platelets from patients with Wiskott-Aldrich syndrome. Thromb. Haemost. 61:10-14
54. Kenney DM, Reid R, Parent DW, Rosen FS, Remold-O'Donnell E. 1994. Evidence implicating calpain (Ca(2+)-dependent neutral protease) in the destructive thrombocytopenia of the Wiskott-Aldrich syndrome. Br. J. Haematol. 87:773-81
55. Altman LC, Snyderman R, Blaese RM. 1974. Abnormalities of chemotactic lymphokine synthesis and mononuclear leukocyte chemotaxis in Wiskott-Aldrich syndrome. J. Clin. Invest. 54: 486-93
56. Badolato R, Sozzani S, Malacarne F, Bresciani S, Fiorini M, Borsatti A, Albertini A, Manotovani A, Ugazio AG, Notarangelo LD. 1998. Monocytes from Wiskott-Aldrich patients display reduced chemotaxis and lack of cell polarization in response to monocyte chemoattractant protein-1 and formyl-methionyl-leucyl-phenylalanine. J. Immunol. 161:1026-33
57. Zicha D, Allen WE, Brickell PM, Kinnon C, Dunn GA, Jones GE, Thrasher AJ. 1998. Chemotaxis of macrophages is abolished in the Wiskott-Aldrich syndrome. Br. J. Haematol. 101:659-65
58. Derry JM, Wiedemann P, Blair P, Wang Y, Kerns JA, Lemahicu V, Godfrey VL, Wilkinson JE, Francke U. 1995. The mouse homolog of the Wiskott-Aldrich syndrome protein (WASP) gene is highly conserved and maps near the scurfy (sf) mutation on the X chromosome. Genomics 29:471-77
59. Parolini O, Berardelli S, Riedl E, Bello-Fernandez C, Strobl H, Majdic O, Knapp W. 1997. Expression of Wiskott-Aldrich syndrome protein (WASP) gene during hematopoietic differentiation. Blood 90:70-75
60. Stewart DM, Treiber-Held S, Kurman CC, Facchetti F, Notarangelo LD, Nelson DL. 1996. Studies of the expression of the Wiskott-Aldrich syndrome protein. J. Clin. Invest. 97:2627-34
61. She J, Rockow S, Tang J, Nishimura R, Skonik EY, Chen M, Magolis B, Li W, 1997. Wiskott-Aldrich syndrome protein is associated with the adapter protein Grb2 and the epidermal growth factor receptor in living cells. Mol. Biol. Cell. 8:1709-21
62. Rivero-Lezcano OM, Marcilla A, Sameshima JH, Robbins KC. 1995. Wiskott-Aldrich syndrome protein physically associates with Nck through Src homology 3 domains. Mol. Cell. Biol. 15:5725-31
63. Miki H, Miura K, Takenawa T. 1996. N-WASP, a novel actin-depolymerizing protein, regulates the cortical cytoskeletal rearrangement in a PIP2-dependent manner downstream of tyrosine kinases. EMBO J. 15:5326-35
64. Fukuoka M, Miki H, Takenawa T. 1997. Identification of N-WASP homologs in human and rat brain. Gene 196:43-48
65. Symons M, Derry JM, Karlak B, Jiang S, Lemahieu V, McCormick F, Francke U, Abo A. 1996. Wiskott-Aldrich syndrome protein, a novel effector for the GTPaseCDC42Hs, is implicated in actin polymerization. Cell 84:723-34
66. Li R. 1997. Bee I, a yeast protein with homology to Wiskott-Aldrich syndrome protein, is critical for the assembly of conical actin assembly. J. Cell Biol. 136:649-58
67. Bear JE, Rawls JF, Saxe CL. 1998. SCAR, a WASP-related protein, isolated as a suppressor of receptor defects in late Dietyostelium development. J. Cell Biol. 142:1325-35
68. Lechler T, Li R. 1997. In vitro reconstitution of cortical actin assembly sites in budding yeast. J. Cell Biol. 138:95-103
69. Snapper SB, Rosen FS, Mizoguchi E, Cohen P, Knan W, Liu C-H, Hagemann TI., Kwan S-P, Ferrini R, Davidson L, Bhan AK, Alt FW. 1998. Wiskott-Aldrich syndrome protein-deficient mice reveal a role for WASP in T but not B cell activation. Immunity 9:81-90
70. Petrella A, Doti V, Agosti P, Giarrusso C, Vitale D, Bond HM, Cuomao P, Tassone P, Franco B, Ballabio A, Venuta S, Morrone G. 1998. A 5′ regulatory sequence containing two Ets motifs controls the expression of the Wiskott-Aldrich syndrome protein (WASP) gene in human hematopoietic cells. Blood 91:4554-60
71. Yu H, Chen J, Feng S, Dalgarno D, Brauer A, Schreiber S. 1994. Structural basis for the binding of proline-rich polypeptides to SH3 domains. Cell 72:933-45
72. Pawson T. 1995. Protein modules and signalling networks. Nature 373:573-80
73. Burbelo PD, Drechsel D, Hall A. 1995. A conserved binding motif defines numerous candidate target proteins for both Cdc42 and Rac GTPases. J. Biol. Chem. 270:29071-4
74. Kolluri R, Tolias KF, Carpenter CL, Rosen FS, Kirchhausen T. 1996. Direct interaction of the Wiskott-Aldrich syndrome protein with the GTPase Cdc42. Proc. Natl. Acad. Sci. USA 93:5615-8
75. Aspenstrom P, Lindberg U, Hall A. 1996. Two GTPases, Cdc42 and Rac, bind directly to a protein implicated in the immunodeficiency disorder Wiskott-Aldrich syndrome. Curr. Biol. 6:70-75
76. Hall A. 1998. Rbo GTPases and the actin cytoskeleton. Science 279:509-14
77. Reif K, Cantrell DA. 1998. Networking Rho family GTPases in lymphocytes. Immunity 8:395-401
78. Ponting CP, Phillips C. 1997. Identification of homer as a homologue of the Wiskott-Aldrich syndrome protein suggests a receptor-binding function for WH1 domains. J. Mol. Med. 75:769-71
79. Donnelly SF, Pocklington MJ, Pallotta D, Orr E. 1993. A proline-rich protein, verprolin, involved in cytoskeletal organization and cellular growth in the yeast Saccharomyces cerevisiae. Mol. Microbiol. 10:585-96
80. Vaduva G, Martin NC, Hopper AK. 1997. Actin-binding verprolin is a polarity development protein required for the morphogenesis and function of the yeast actin cyloskeleton. J. Cell Biol. 139:1821-33
81. Ramesh N, Anton IM, Hartwig JH, Geha RS. 1997. WIP, a protein associated with Wiskott-Aldrich syndrome protein induces actin polymerization and redistribution in lymphoid cells. Proc. Natl. Acad. Sci. USA 94:14671-76
82. Miki H, Takenawa T. 1998. Direct binding of the verprolin-homology domain in N-WASP to actin is essential for cytoskeletal reorganization. Biochem. Biophys. Res. Commun. 243:73-78
83. Nishida E, Mackawa S, Sakai H. 1984. Cofilin, a protein in porcine brain that hinds to actin filaments and inhibits their interactions with myosin and tropomyosin. Biochemistry 23:5307-17
84. Miki H, Sasaki T, Takai Y, Takenawa T. 1998. Induction of filopodium formation by a WASP-related actin-depolymerizing protein N-WASP. Nature 391:93-96
85. Rhoads AR, Friedberg F. 1997. Sequence motifs for calmodulin recognition. FASEB J. 11:331-40
86. Stowers L, Yelon D, Berg LJ, Chant J. 1995. Regulation of the polarization of T cells toward antigen-presenting cells by Ras-related GTPase CDC42. Proc. Natl. Acad. Sci. USA 92:5027-31
87. Rudolph MG, Bayer P, Abo A, Kuhlmann J, Vetter TR, Wittinghofer A. 1998. The Cdc42/Rac interactive binding region motif of the Wiskott-Aldrich syndrome protein (WASP) is necessary but not sufficient for tight binding to Cdc42 and structure formation. J. Biol. Chem. 273:18067-76
88. Banin S, Truong O, Katz DR, Waterfield MD, Brickell PM, Gout I. 1996. Wiskott-Aldrich syndrome protein (WASp) is a binding partner for c-Src family protein-tyrosine kinases. Curr. Biol. 6:981-88
89. Bunnell S, Henry P, Kolluri R, Kirchhausen T, Rickles R, Berg L. 1996. Identification of ITK/Tsk Src homology 3 domain ligands. J. Biol. Chem. 271: 25646-56
90. Cory G, MacCarthy-Morrogh L, Banin S, Gout I, Brickell P, Levinsky R, Kinnon C, Lovering R. 1996. Evidence that the Wiskott-Aldrich syndrome protein may be involved in lymphoid cell signaling pathways. J. Immunol. 157:3791-95
91. Finan PM, Soames CJ, Wilson L, Nelson DL, Stewart DM, Truong O, Hsuan JJ, Kellie S. 1996. Identification of regions of the Wiskott-Aldrich syndrome protein responsible for association with selected Src homology 3 domains. J. Biol Chem. 271:26291-95
92. Miki H, Nonoyama S, Zhu Q, Aruffo A, Ochs HD, Takenawa T 1997. Tyrosine kinase signaling regulates Wiskott-Aldrich syndrome protein function, which is essential for megakaryocyte differentiation. Cell Growth Different. 8:195-202
93. Lehmann JM, Riethmuller G, Johnson JP. 1990. Nck, a melanoma cDNA encoding a cytoplasmic protein consisting of the src homology units SH2 and SH3. Nucleic Acids Res. 18:1048
94. Galisteo ML, Chernoff J, Su YC, Skolnik EY, Schlessinger J. 1996. The adaptor protein Nek links receptor tyrosine kinases with the serine-threonine kinase Pak I. J. Biol. Chem. 271:20997-1000
95. Lu W, Katz S, Gupta R, Mayer BJ. 1997. Activation of Pak by membrane localization mediated by an SH3 domain from the adaptor protein Nck. Curr. Biol. 7:85-94
96. Quilliam LA, Lambert QT, Mickelson-Young LA, Westwick JK, Sparks AB, Kay BK, Jenkins NA, Gilbert DJ, Copeland NG, Der CJ. 1996. Isolation of a NCK-associated kinase, PRK2, an SH3-binding protein and potential effector of Rho protein signaling. J. Biol. Chem. 271:28772-76
97. Sells MA, Knaus UG, Bagrodia S, Ambrose DM, Bokoch GM, Chernoff J. 1997. Human p21-activated kinase (Pak1) regulates actin organization in mammalian cells. Curr. Biol. 7:202-10
98. Su YC, Han J, Xu S, Cobb M, Skolnik EY. 1997. NIK is a new Ste20-related kinase that binds NCK and MEKKI and activates the SAPK/JNK cascade via a conserved regulatory domain. Embo. J. 16:1279-90
99. Garrity PA, Rao Y, Salecker I, McGlade J, Pawson T, Zipursky SL. 1996. Drosophila photoreceptor axon guidance and targeting requires the dreadlocks SH2/SH3 adaptor protein. Cell 85:639-50
100. Anton IM, Lu W, Mayer BJ, Ramesh N, Geha RS. 1998. The Wiskott-Aldrich Syndrome protein-interacting protein (WIP) binds to the adaptor protein Nck. J. Biol. Chem. 273:20992-95
101. da Silva AJ, Li Z, de Vera C, Canto E, Findell P, Rudd CE. 1997. Cloning of a novel T-cell protein FYB that binds FYN and SH2-domain-containing leukocyte protein 76 and modulates interleukin 2 production. Proc. Natl. Acad. Sci. USA 94:7493-98
102. Marie-Cardine A, Bruyns E, Eckerskom C, Kirchgessner H, Meuer SC, Schraven B. 1997. Molecular cloning of SKAP55, a novel protein that associates with the protein tyrosine kinase p59fyn in human T-lymphocytes. J. Biol. Chem. 272:16077-80
103. Pedraza-Alva G, Merida LB, Burakoff SJ, Rosenstein Y. 1996. CD43-specific activation of T cells induces association of CD43 to Fyn kinase. J. Biol. Chem. 271:27564-68
104. Prasad KV, Janssen O, Kapeller R, Raab M, Cantley LC, Rudd CE. 1993. Src-homology 3 domain of protein kinase p59fyn mediates binding to phosphatidylinositol 3-kinase in T cells. Proc. Natl. Acad. Sci. USA 90:7366-70
105. Raab M, Cai YC, Bunnell SC, Heyeck SD, Berg LJ, Rudd CE. 1995. p56Lck and p59Fyn regulate CD28 binding to phosphatidylinositol 3-kinase, growth factor receptor-bound protein GRB-2, and T cell-specific protein-tyrosine kinase ITK: implications for T-cell costimulation. Proc. Natl. Acad. Sci. USA 92:8891-95
106. Fusaki N, Iwamatsu A, Iwashima M, Fujisawa J. 1997. Interaction between Sam68 and Src family tyrosine kinases, Fyn and Lck, in T cell receptor signaling. J. Biol. Chem. 272:6214-19
107. Fortner KA, Russell JQ, Budd RC. 1998. Down-modulation of CD2 delays deletion of superantigen-responsive T cells. Eur. J. Immunol. 28:70-79
108. Atkinson EA, Ostergaard H, Kane K, Pinkoski MJ, Caputo A, Olszowy MW, Bleackley RC. 1996. A physical interaction between the cell death protein Fas and the tyrosine kinase p59fynT. J. Biol. Chem. 271:5968-71
109. Helmke S, Pfenninger KH. 1995. Growth cone enrichment and cytoskeletal association of non-receptor tyrosine kinases. Cell Motil. Cytoskeleton 30:194-207
110. Thomas SM, Soriano P, Imamoto A. 1995. Specific and redundant roles of Src and Fyn in organizing the cytoskeleton, Nature 376:267-71
111. Calautti E, Missero C, Stein PL, Ezzell RM, Dotto GP. 1995. fyn tyrosine kinase is involved in keratinocyte differentiation control. Genes Dev. 9:2279-91
112. Miki H, Mirua K, Matuoka K, Nakata T, Horokawa N, Orita S, Kaibuchi K, Takai Y, Takenawa T. 1994. Association of Ash/Grb2 with dynamin through the Src homology 3 domain. J. Biol. Chem. 269:5489-92
113. Matuoka K, Shibasaki F, Shibata M, Takenawa T. 1993. Ash/Grb-2, a SH2/SH3-containing protein, couples to signaling for mitogenesis and cytoskeletal reorganization by EGF and PDGF. EMBO J. 12:3467-73
114. Wu Y, Spencer SD, Lasky LA. 1998. Tyrosine phosphorylation regulates the SH3-mediated binding of the Wiskott-Aldrich syndrome protein to PSTPIP, a cytoskeletal-associated protein. J. Biol. Chem. 273:5765-70
115. Spencer S, Dowbenko D, Cheng J, Li W, Brush J, Utzig S, Simanis V, Lasky LA. 1997. PSTPIP: a tyrosine phosphorylated cleavage furrow-associated protein that is a substrate for a PEST tyrosine phosphatase. J. Cell Biol. 138:845-60
116. Zoladek T, Vaduva G, Hunter LA, Boguta M, Go BD, Martin NC, Hopper AK. 1995. Mutations altering the mitochondrial-cytoplasmic distribution of Mod5p implicate the actin cytoskeleton and mRNA 3′ ends and/or protein synthesis in mitochondrial delivery. Mol. Cell. Biol. 12:6884-94
117. Stossel TP. 1993. On the crawling of animal cells. Science 260:1086-94
118. Hartwig J, Bokoch G, Carpenter C, Janmey P, Taylor L, Toker A, Stossel T. 1995. Thrombin receptor ligation and activated Rac uncap actin filament barbed ends through phosphoinositide synthesis in permeabilized human platelets. Cell 82:643-53
119. Gilmore A, Burridge K. 1996. Regulation of vinculin binding to talin and actin by phosphatidyl-inositol-4-5-bisphosphate. Nature 381:531-35
120. Derry JM, Kerns JA, Weinberg KI, Ochs HD, Volpini V, Estivill X, Walker AP, Francke U. 1995. WASP gene mutations in Wiskott-Aldrich syndrome and X-linked thrombocytopenia. Hum. Mol. Gen. 4:1127-35
121. Kolluri R, Shehabeldin A, Peacocke M, Lamhonwah AM, Teichert-Kuliszewska K, Weissman SM, Siminovitch KA. 1995. Identification of WASP mutations in patients with Wiskott-Aldrich syndrome and isolated thrombocytopenia reveals allelic heterogeneity at the WAS locus. Hum. Mol. Gen. 4:1119-26
122. Kwan SP, Hagemann TL, Blaese RM, Knutsen A, Rosen FS. 1995. Scanning of the Wiskott-Aldrich syndrome (WAS) gene: identification of 18 novel alterations including a possible mutation hotspot at Arg86 resulting in thrombocytopenia, a mild WAS phenotype. Hum. Mol. Gen. 4:1995-98
123. Wengler GS, Notarangelo LD, Giliani S, Pirastru MG, Ugazio AG, Parolini O. 1995. Mutation analysis in Wiskott Aldrich syndrome on chorionic villus DNA. Lancet 346:641-42
124. Wengler GS, Notarangelo LD, Berardelli S, Pollonni G, Mella P, Fasth A, Ugazio AG, Parolini O. 1995. High prevalence of nonsense, frame shift, and splice-site mutations in 16 patients with full-blown Wiskott-Aldrich syndrome. Blood 86:3648-54
125. Schindelhauer D, Weiss M, Hellebrand H, Golla A, Hergersberg M, Seger R, Belohradsky BH, Meindl A. 1996. Wiskott-Aldrich syndrome: no strict genotype-phenotype correlations but clustering of missense mutations in the amino-terminal part of the WASP gene product. Hum. Genet. 98:68-76
126. Greer WL, Shehabeldin A, Schulman J, Junker A, Siminovitch K. 1996. Identification of WASP mutations, mutation hotspots, and genotype-phenotype disparities in 24 patients with the Wiskott-Aldrich syndrome. Hum. Genet. 98:685-90
127. de Saint-Basile G, Lagelouse RD, Lambert N, Schwarz K, Le Mareck B, Odent S, Sehlegel N, Fischer A. 1996. Isolated X-linked thrombocytopenia in two unrelated families is associated with point mutations in the Wiskott-Aldrich syndrome protein gene. J. Pediatr. 129:56-62
128. Remold-O'Donnell E, Cooley J, Shcherbina A, Hagemann TL, Kwan SP, Kenney DM, Rosen FS. 1997. Variable expression of WASP in B cell lines of Wiskott-Aldrich syndrome patients. J. Immunol. 158:4021-25
129. MacCarthy-Morrogh L, Gaspar HB, Wang YC, Katz F, Thompson L, Layton M, Jones AM, Kinnon C. 1998. Absence of expression of the Wiskott-Aldrich syndrome protein in peripheral blood cells of Wiskott-Aldrich syndrome patients. Clin. Immunol. Immunopathol. 88:22-27
130. Kondoh T, Hayashi K, Matsumoto T, Yoshimoto M, Morio T, Yata J, Tsuji Y. 1995. Two sisters with clinical diagnosis of Wiskott-Aldrich syndrome: Is the condition in the family autosomal recessive? Am. J. Med. Genet. 60:364-69
131. Rocca B, Bellacosa A, De CR, Neri G, Della VM, Maggiano N, Rumi C, Landolfi R. 1996. Wiskott-Aldrich syndrome: report of an autosomal dominant variant. Blood 87:4538-43
132. Parolini O, Ressmann G, Haas OA, Pawlowsky J, Gadner H, Knapp W, Holter W. 1998. X-linked Wiskott-Aldrich syndrome in a girl. N. Engl. J. Med. 338:291-5
133. Hsieh KH, Chang MH, Lee CY, Wang CY. 1988. Wiskott-Aldrich syndrome and inflammatory bowel disease. Ann. Aller. 60:429-31
134. Morales V, Snapper SB, Blumberg R. 1996. Probing the gastrointestinal immune function using transgenic and knockout technology. Current Opin. Gastroenterol. 12:577-83
135. Nobes CD, Hall A. 1995. Rho, rac, and cdc42 GTPases regulate the assembly of multimolecular focal complexes associated with actin stress fibers, lamellipodia, and filopodia. Cell 81:53-62
136. PAK and the JNK/SAPK MAP kinase cascade. Cell 87:519-29
137. Joneson T, McDonough M, Bar-Sagi D, Van Aelst L. 1997. RAC regulation of actin polymerization and proliferation by a pathway distinct from Jun kinase. Science 274:1347-56
138. Zigmond SH. 1998. The Arp2/3 complex gets to the point. Curr. Biol. 8: R654-R7
139. Pantaloni D, Carlier M-F. 1993. How profilin promotes actin filament assembly in the presence of thymosinB4. Cell 75:1007-14
140. Geiger B, Rosen D, Berke G. 1982. Spatial relationships of microtubule-organizing centers and the contact area of cytotoxic T lymphoyctes and target cells. J. Cell Biol. 95:137-43
141. Kupfer A, Swain SL, Janeway CA, Singer SJ. 1986. The specific direct interaction of helper T cells and antigen-presenting B cells. Proc. Natl. Acad. Sci. (USA) 83:8080-3
142. Kupfer H, Monks CRF, Kupfer A. 1994. Small splenic B cells that bind to antigen-specific T helper (Th) cells and face the site of cytokine production in the the Th cells selectively proliferate: immunofluorescence microscopic studies of Th-B antigen presenting cell interactions. J. Exp. Med. 179:1507-15
143. Rozdzial MM, Maliseen B, Finkel TH. 1995. Tyrosine-phosphorylated T cell receptor ζ chain associates with the actin cytoskeleton upon activation of mature T lymphocytes. Immunity 3:623-33
144. Caplan S, Zeliger S, Wnag L, Baniyash M. 1995. Cell-surface-expressed T-cell antigen-receptor ζ chain is associated with the cytoskeleton. Proc. Natl. Acad. Sci. USA 92:4768-72
145. Geppert T, Lipsky P. 1991. Association of various T cell-surface molecules with the cytoskeleton. Effect of cross-linking and activation. J. Immunol. 146:3298-305
146. Phatak PD, Packman CH. 1994. Engagement of the T-cell antigen receptor by anti-CD3 monoclonal antibody causes a rapid increase in lymphocyte F-actin. J. Cell. Physiol. 159:365-70
147. Lowin-Kropf B, Shapiro VS, Weiss A. 1998. Cytoskeletal polarization of T cells is regulated by an immunoreceptor tyrosine-based activation motif-dependent mechanism, J. Cell. Biol. 140:861-71
148. Parsey M, Lewis G. 1993. Actin polymerization and pseudopod reorganization accompany anti-CD3 growth arrest in Jurkat T cells. J. Immunol. 151:1881-93
149. Pardi R, Inverardi L, Rugarli C, Bender JR. 1992. Antigen-receptor complex stimulation triggers protein kinase C-dependent CD11a/CD18-cytoskeleton association in T lymphocytes. J. Cell. Biol. 116:1211-20
150. Selliah N, Bartik MM, Carlson SL, Brooks WH, Roszman TL. 1995. cAMP accumulation in T-cells inhibits anti-CD3 monoclonal antibody-induced actin polymerization. J. Neuroimmunol. 56:107
151. Selliah N, Brooks WH, Roszman TL. 1996. Proteolytic cleavage of α-actinin by calpain in T cells stimulated with anti-CD3 monoclonal antibody. J. Immunol. 156:3215-21
152. Melamed I. Downey G, Altories K, Roifman C. 1991. Microfilament assembly is required for antigen-receptor-mediated activation of human B lymphocytes. J. Immunol. 147:1139-46
153. Geppert TD, Lipsky PE. 1990. Regulatory role of microfilaments in the induction of T4 cell proliferation and interkeukin 2 production. Cell. Immunol. 131:205-18
154. DeBell KE, Conti A, Alava MA, Hoffman T, Bonvini E. 1992. Microfilament assembly modulates phospholipase C-mediated signal transaction by the TCR/CD3 in murine T helper lymphocytes. J. Immunol. 7:2271-80
155. Cox D, Chang P, Kuosaki T, Greenberg S. 1996. Syk tyrosine kinase is required for immunoreceptor tyrosine activation motif-dependent actin assembly. J. Cell. Biol. 140:861-70
156. Phatak P, Packman C, Lichtman M. 1988. Protein kinase C modulates actin conformation in human T lymphocytes. J. Immunol. 2929-34
157. Monks CRF, Kupfer H, Tamir I, Barlow A, Kupfer A. 1997. Selective modulation of protein kinase C-θ during T-cell activation, Nature 385:83-6
158. Holsinger LJ, Graef IA, Swat W, Chi T, Bautista DM, Davidson L, Lewis RS, Alt FW, Crabtree GR. 1998. Defects in actin cap formation in vav-deficient mice implicate an actin requirement for lymphocyte signal transduction. Curr. Biol. 8:563-72
159. Fischer K-D, Kong Y-Y, Nishina H, Tedfor D, Manengere LEM, Kozieradzki I, Sasaki T, Starr M, Chan G, Gardener S, Hghiem MP, Bouchard D, Barbacid M, Bernstein A, Penninger JM. 1998. Vav is a regulator of cytoskeletal reorganization mediated by the T-cell receptor. Curr. Biol. 8:554-62
160. Valitutti S, Muller S, Cella M, Padovan E, Lanzavecchia A. 1995. Serial triggering of many T-cell receptors by a few peptide-MHC complexes. Nature 375:148-51
161. Valitutti S, Dessing M, Aktories H. Gallait H, Lanzavecchia A. 1995. Sustained signaling leading to T cell activation results from prolonged T cell receptor occupancy. Role of T cell actin cytoskeleton. J. Exp. Med. 181:577-84
162. Shaw A, Duslin M. 1997. Making the T cell receptor go the distance: a topological view of T cell activation. Immunity 6:361-9
163. Monks CRF, Freiberg BA, Kupfer H, Sciaky N, Kupfer A. 1998. Three-dimensional segregation of supramolecular activation clusters in T-cells. Nature 395:82-6
164. Dustin ML, Olszowy MW, Holdorf AD, Li I, Bromley S, Desai N, Widder P, Rosenberger F, Anton van der Merwe P, Allen P, Shaw AS. 1998. A novel adaptor protein orchestrates receptor patterning and cytoskeletal polarity in T-cell contacts. Cell 94:667-77
165. Taylor RB, Duttus PH, Raff MC, de Petris S. 1971. Redistribution and pinocytosis of lymphocyte surface immunoglobulin molecules induced by anti-immunoglobulin antibody. Nat. New Biol. 233:225
166. de Petris S. 1974. Inhibition and reversal of capping by cytochalasin B, vinblastine, and colchicine. Nature 250:54-5
167. Kammer GM, Smith JA, Mitchell R, 1983. Capping of human T cell specific determinants; kinetics of capping and receptor re-expression and regulation by
168. Zhang R, Alt FW, Davidson L, Orkin SH, Swat W. 1995. Defective signalling through the T-and B-cell antigen receptors in lymphoid cells lacking the vav proto-oncogene. Nature 374:470-3
169. Fischer KD, Zmuldzinas A, Gardner S, Barbacid M, Bernstein A, Guidos C. 1995. Defective T-cell receptor signalling and positive selection of Vav-deficient CD4+ CDS+ thymocytes. Nature 374:474-7
170. Tarakhovsky A, Turner M, Schaal S, Mee PJ, Duddy LP, Rajewsky K, Tybulewicz VL. 1995. Defective antigen receptor-mediated proliferation of B and T cells in the absence of Vav. Nature 374:467-70
171. Olson MF, Pasteris NG, Gorski JL, Hall A. 1996. Faciogenital dysplasia protein (FGDI) and Vav, two related proteins required for normal embryonic development, arc upstream regulators of Rho GTPases. Curr. Biol. 6:1628-33
172. Oda A, Ochs HD, Druker BJ, Ozaki K, Watanabe C, Handa M, Miyakawa Y, Ikeda Y. 1998. Collagen induces tyrosine phosphorylation of Wiskott-Aldrich Syndrome Protein in human platelets. Blood 92:1852-8